BILLS-110hr1496ih.pdf
House Resolutions
0 pages
Page
of 0
Loading OCR text...
No OCR text available for this page.
Failed to load OCR text.
DATE (48)
VerDate Aug 31 2005
2007
1986
2004
15, 2007
35
years
2 years
a taxable year
1990
annual
daily
each year
December 31, 2006
year
24
years
45 days
any taxable year
the number of days
1496 IH
SECTION 1
60 days
9
2007
the later of 60 days
the taxable year
today
31 2005
less than 24 months
the day before the date
year 2007
December 31
each day
1ST SESSION H. R. 1496
‘65
11
10 or more years
each subsequent fiscal year
the end of calendar year
later than 5 years
later than 1 year
18
year
fiscal year 2008
24
2007
2011
MARCH 13, 2007
18
2007
20
2007
annually
the day before
EVENT (2)
the General Schedule
the ‘‘Beating Infections
GPE (4)
1496 IH
the United States
United States
the United States of America
LOC (2)
IH
Acinetobacter
NORP (3)
APPROPRIATIONS.—To
Cosmetic
Americans
ORG (50)
SEC
Commission
the Federal Food, Drug
Research and Development Act
the Internal Revenue Code
Federal
Health and Human Services
the Federal Food
Food, Drug
the Public Health Service
Congress
uct
the Beating Infections through Research
the Public Health Service Act
XDR
The Institute of Medicine
TB
Health Affairs
STAFF OF COMMISSION
Nation
Food and Drug Administration
the Beating Infections
Infections through Research and Development
merce
Diseases Society of America
EXPENSES.—Each
Institute
Defense
the Beating Infections through
Homeland Security
the ‘Commission
the Antimicrobial Resistance Task Force
the Commissioner of Food and Drugs
the National Biodefense Science Board
the Environmental Protection
the Food and Drug Administration
Control and Prevention
the Committee on Energy
the Occupational Safety and Health Adminis-
General Sched-
State
The Centers for Disease Control
General Services
United
the Department of Veterans Affairs
UCTS MANUFACTURING FACILITIES
8) MEETINGS.—The Commission
1
Commission
PERSON (4)
Subparagraph
BAIRD
MATHESON
CUBIN
Topic Classifications
congressional legislation
94.0%
public health
67.4%
government oversight
18.2%
Extracted Keywords
resistant
drug resistant
xdr
resistance
tuberculosis
infectious
drug
pandemic
drugs
companies
infections
pharmaceutical
diagnostic
research development
anti
Forensic Analysis
PDF Metadata
- Creator
- ACOMP.exe WinVer 1c15 Aug 31 2005
- ModDate
- D:20230111022520Z
- Producer
- Acrobat Distiller 4.0 for Windows; modified using iText® Core 7.2.3 (production version) ©2000-2022 iText Group NV, Government Publishing Office
- CreationDate
- D:20070315204736Z
Sentiment
Polarity
Neutral
0.040
Subjectivity
44%
Objective
No crisis correlations found for this document.
The ML pipeline may still be processing.